Ligand validation:6SPL

SB4: 4-(4-FLUOROPHENYL)-1-(4-PIPERIDINYL)-5-(2-AMINO-4-PYRIMIDINYL)-IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SPL_SB4_A_401	93%	57%	0.068	0.964	0.84	0.8	1	-	0	0	100%	1
6Y7X_SB4_A_401	94%	64%	0.075	0.973	0.83	0.56	1	-	2	0	100%	1
6SP9_SB4_A_401	91%	60%	0.076	0.964	0.78	0.74	-	-	2	0	100%	1
6Y7W_SB4_A_401	91%	63%	0.083	0.968	0.8	0.61	-	-	2	0	100%	1
6Y85_SB4_A_402	88%	58%	0.082	0.956	0.79	0.81	-	-	1	0	100%	1
6YCU_SB4_A_401	87%	61%	0.08	0.953	0.81	0.68	-	-	2	0	100%	1
4LOQ_SB4_A_401	83%	6%	0.104	0.963	3.07	2.03	3	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.